BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN
There's no reason to be bitter about the plummeting share price of Israeli pharmaceutical company Teva, as it makes sense, according to CEO Kåre Schultz, who has not yet managed to generate value for the firm's hard-pressed shareholders.
"I'm alright with it. In my view, we've managed to save the company, reorganize it and bring down debts, but we're not done yet," says Schultz.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Rumored GN purchase unlikely but not impossible, say analysts
A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.
EMA begins analyzing Bavarian Nordic's vaccine against monkeypox
Prior to deciding on a shared European vaccine supply purchase, the European Medicines Agency has begun analyzing the Danish firm’s smallpox vaccine against monkeypox.
Bavarian Nordic eyes European monkeypox approval for smallpox vaccine
Bavarian Nordic’s smallpox vaccine, Jynneos, hasn’t yet been approved for monkeypox in Europe, a fact that hasn’t stopped countries there from lining up to secure vaccine supplies in light of the recent outbreak.
New CFO wants to shake things up at WSA
A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.
Chinese patent expiration dates draw closer for Novo Nordisk
In coming years, Novo Nordisk will take blows in the shape of several patents terminating on the second-biggest market for the firm, a Danish media reports.
Clinical Trial Administrator 
Senior IT Network Engineer 
Production Director 
Strategic Procurement Manager, Direct Spend (Category Manager) 
Senior Project Manager (GMP - Life Science) 
Senior Chemical Safety Advisor 
(Senior) Drug Substance Specialist 
Key Account Manager, Europe and Asia 
Analytical Senior Scientist 
Account Manager 
Clinical Trial Manager for development of in vitro diagnostics 
Director for innovative pre-clinical testing unit 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Senior Manager, Clinical Trial Budget 
Client Talent Acquisition Specialist 
Communications Consultant